Adrenergic beta-3 Receptor Agonists
Showing 26 - 50 of >10,000
Emergence Agitation Trial in Shanghai (Esketamine, Sevoflurane)
Recruiting
- Emergence Agitation
-
Shanghai, Shanghai, ChinaAnesthesiology Department of Affiliated Eye and ENT Hospital, Fu
Dec 3, 2022
Recurrent Acute Lymphoblastic Leukemia, Recurrent B Acute Lymphoblastic Leukemia, Recurrent B-Cell Prolymphocytic Leukemia Trial
Recruiting
- Recurrent Acute Lymphoblastic Leukemia
- +15 more
- Anti-CD19/CD20/CD22 CAR T-Cells
- +2 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Nov 4, 2022
Recurrent DLBCL, Refractory DLBCL Trial in Sacramento (Chimeric Antigen Receptor T-Cell Therapy, Cyclophosphamide, Fludarabine
Recruiting
- Recurrent Diffuse Large B-Cell Lymphoma
- Refractory Diffuse Large B-Cell Lymphoma
- Chimeric Antigen Receptor T-Cell Therapy
- +3 more
-
Sacramento, CaliforniaUniversity of California Davis Comprehensive Cancer Center
Mar 8, 2022
Type 2 Diabetes Trial in Sherbrooke (Mirabegron, Bisoprolol Fumarate)
Completed
- Type 2 Diabetes
- Mirabegron
- Bisoprolol Fumarate
-
Sherbrooke, Quebec, CanadaCentre de recherche du CHUS
Oct 31, 2022
Symptomatic Parkinson Disease, REM Sleep Behavior Disorder, Pre-motor Parkinson's Disease Trial in Los Angeles (Terazosin
Recruiting
- Symptomatic Parkinson Disease
- +2 more
- Terazosin therapy
-
Los Angeles, CaliforniaCedars Sinai Medical Center
Aug 23, 2022
Recurrent Neuroblastoma, Recurrent Osteosarcoma, Refractory Neuroblastoma Trial in Bethesda, Seattle, Madison (Cyclophosphamide,
Recruiting
- Recurrent Neuroblastoma
- +3 more
- Cyclophosphamide
- +2 more
-
Palo Alto, California
- +3 more
Jan 25, 2023
Adrenergic Beta-Receptor Blockader, Troponin Levels, Cardiomyopathy, Post-surgical Trial in Saint Louis (metoprolol)
Completed
- Adrenergic Beta-Receptor Blockader
- +2 more
-
Saint Louis, MissouriBarnes-Jewish Hospital/Washington University in St. Louis School
Jan 23, 2020
Adult Acute Myeloid Leukemia in Remission, Acute Biphenotypic Leukemia, Early Relapse of Acute Myeloid Leukemia Trial in Duarte
Active, not recruiting
- Adult Acute Myeloid Leukemia in Remission
- +12 more
- cyclophosphamide
- +4 more
-
Duarte, CaliforniaCity of Hope Medical Center
Feb 17, 2022
Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8 Trial in Duarte
Recruiting
- Castration-Resistant Prostate Carcinoma
- +4 more
- Autologous Anti-PSCA-CAR-4-1BB/TCRzeta-CD19t-expressing T-lymphocytes
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
Mar 17, 2022
Thermogenesis Trial in Basel (Fenoterol, Mild cold exposure)
Recruiting
- Thermogenesis
- Fenoterol
- Mild cold exposure
-
Basel, SwitzerlandUniversity Hospital Basel, Dept. of Endocrinology
Apr 27, 2022
Morbid Obesity, Metabolic Syndrome, Diabetes Trial in Columbia (GLP-1 receptor agonist)
Not yet recruiting
- Morbid Obesity
- +4 more
- GLP-1 receptor agonist
-
Columbia, MissouriUniversity of Missouri Hospital
Nov 20, 2023
Asthma Trial in Hackensack, New York (Fluticasone with salmeterol, Fluticasone HFA)
Completed
- Asthma
- Fluticasone with salmeterol
- +3 more
-
Hackensack, New Jersey
- +2 more
Oct 12, 2022
IBD Trial in Tanta (Mesalamine, Fenofibrate 160mg)
Recruiting
- Inflammatory Bowel Diseases
- Mesalamine
- Fenofibrate 160mg
-
Tanta, EgyptTanta Unuversity
Mar 6, 2023
Intracerebral Haemorrhage Trial (mirabegron, usual care)
Not yet recruiting
- Intracerebral Haemorrhage
- mirabegron
- usual care
- (no location specified)
Oct 18, 2022
Anesthesia Intubation Complication Trial in Zagazig (Nebulized Dexmedetomidine, Nebulized Lidocaine, Intravenous
Not yet recruiting
- Anesthesia Intubation Complication
- Nebulized Dexmedetomidine
- +3 more
-
Zagazig, Al-Sharkia, EgyptFaculty of medicine, Zagazig University
Jul 4, 2023
The Genetics of Severe Asthma in Children
Completed
- Asthma
-
Hartford, ConnecticutConnecticut Children's Medical Center
Oct 10, 2022
Asthma Trial in Spain (To compare in both treatment arms the percentage of patients controlled at week 52.)
Recruiting
- Asthma
- To compare in both treatment arms the percentage of patients controlled at week 52.
-
Inca, Baleares, Spain
- +16 more
Jun 16, 2023
Chronic Anergic-anhedonic Depression Open Trial
Recruiting
- Depressive Disorder, Treatment-Resistant
-
Strasbourg, FranceCENTRE DE NEUROMODULATION NON INVASIVE DE STRASBOURG (CEMNIS) -
Oct 25, 2023
Therapeutic Drug Use for CKD Patients
Active, not recruiting
- Chronic Kidney Disease
- angiotensin converting enzyme inhibitors, angiotensin II receptor blockers, DPP-4 inhibitors, GLP-1 receptor agonists, SGLT2 inhibitors, calcium channel blockers, β Receptor blocker
-
Jinan, Shandong, ChinaXiao Li,MD
Apr 18, 2023
Resting Energy Expenditure, Thermogenesis, Brown Adipose Tissue Trial in Bloomington (Mirabegron, Placebo)
Recruiting
- Resting Energy Expenditure
- +2 more
- Mirabegron
- Placebo
-
Bloomington, IndianaIndiana University
Aug 4, 2023
Breast Cancer With or Without BRCA Mutation
Recruiting
- Breast Cancer
- Androgen receptor status and BRCA mutation
-
Varanasi, UP, IndiaBanaras Hindu University
Jun 2, 2022
Pulmonary Disease, Chronic Obstructive Trial in Waterbury, Charlotte, Layton (Inhaled corticosteroids/long-acting
Withdrawn
- Pulmonary Disease, Chronic Obstructive
- Inhaled corticosteroids/long-acting beta2-adrenergic/long-acting muscarinic receptor antagonists
- Fluticasone furoate/umeclidinium/vilanterol
-
Waterbury, Connecticut
- +2 more
Apr 21, 2020
End-Stage Kidney Disease, End-Stage Renal Disease Trial in Boston, Minneapolis, New York (Metoprolol Succinate, Carvedilol)
Not yet recruiting
- End-Stage Kidney Disease
- End-Stage Renal Disease
- Metoprolol Succinate
- Carvedilol
-
Boston, Massachusetts
- +4 more
Jun 26, 2023
Ureteral Stent, Stent Related Symptoms Trial in Mansoura (Mirabegron 50 MG, Tamsulosin, Solifenacin Succinate 10 MG)
Recruiting
- Ureteral Stent
- Stent Related Symptoms
- Mirabegron 50 MG
- +3 more
-
Mansoura, DK, EgyptUrology and Nephrology Center
Nov 20, 2021